Stockreport

Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months [Yahoo! Finance]

Actuate Therapeutics, Inc. - Common stock  (ACTU) 
PDF Recent financing provides extended runway through key anticipated regulatory inflection points Additional nonclinical studies are ongoing combining elraglusib with RA [Read more]